M 14 (Methotrexate Sodium 2.5 mg)

Pill with imprint M 14 is Orange, Round and has been identified as Methotrexate Sodium 2.5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Methotrexate is used in the treatment of acute lymphocytic leukemia; acute lymphoblastic leukemia; rheumatoid arthritis; breast cancer; juvenile idiopathic arthritis and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy. Methotrexate 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 14

Methotrexate Sodium

Imprint:

M 14

Strength:

2.5 mg

Color:

Orange

Size:

6.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Antimetabolites
Antipsoriatics
Antirheumatics
Other immunosuppressants

Pregnancy Category:

X - Not for use in pregnancy

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Mylan Pharmaceuticals Inc.

Inactive Ingredients:

• silicon dioxide
• lactose monohydrate
• magnesium stearate
• microcrystalline cellulose
• corn starch
• sodium carbonate monohydrate
• sodium lauryl sulfate
• sodium starch glycolate type A potato
• FD&C Red No. 40

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC Code	Labeler / Repackager
00378-0014	Mylan Pharmaceuticals Inc.
51079-0670	UDL Laboratories Inc.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer